About Subsys® Spray
Subsys® (fentanyl sublingual spray) is manufactured and marketed by Insys Therapeutics and was approved by the FDA in 2012. For a variety of reasons, Subsys® is only FDA-approved for management of breakthrough pain in adult cancer patients who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. In fact, the FDA-approved use of Subsys® requires that any patient taking Subsys® must remain on an around-the-clock opioid when taking Subsys®.
Nevertheless, Insys Therapeutics has been accused of employing aggressive and fraudulent sales and marketing tacticsto persuade doctors to prescribe Subsys® to non-cancer patients. In 2016 the U.S. Department of Justice obtained indictments against former Insys executives who are accused of bribing medical professionals to prescribe the drug “off-label” in a way the FDA did not approve.
Dangers Associated with Subsys®
Subsys® is a powerful opioid and can become addictive. When prescribed to non-cancer or other “off-label” patients, addiction can become a serious issue. In some cases, patients were prescribed Subsys® for migraines or other issues that could have been better treated with a different drug. Some of these patients became addicted to Subsys® and may have experienced very serious adverse effects, including overdose and death.
Trust Our Personal Injury Attorneys With Your Case
The Simon Law Firm, P.C. is passionate about advocating for the rights of the injured. If you or your loved one became addicted to Subsys® because of a negligent prescription or died as the result of an overdose, our firm wants to help. It is the responsibility of every healthcare professional to prescribe medicines that are fitting to the ailment, and failure to do so can be considered negligence.